Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial

A Ana C. Veneziani S Stephanie Lheureux D Douglas G. Millar N Neesha Dhani I Ilaria Colombo A Ainhoa Madariaga P Pamela Soberanis Pina S Swati Atale Y Yin-Ling Chan J Joshua Lee (Department of Process Research and Development) J Janelle Ramsahai J Judy Quintos L Lisa Wang X Xuan Li (Department of Chemistry) V Valerie Bowering P Pam Ohashi B Ben Wang (State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, China) A Amit M. Oza

Article Details

Volume / Issue Vol. 17, Issue 1
Published May 14, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (18)

A

Ana C. Veneziani

S

Stephanie Lheureux

D

Douglas G. Millar

N

Neesha Dhani

I

Ilaria Colombo

A

Ainhoa Madariaga

P

Pamela Soberanis Pina

S

Swati Atale

Y

Yin-Ling Chan

J

Joshua Lee

Department of Process Research and Development

J

Janelle Ramsahai

J

Judy Quintos

L

Lisa Wang

X

Xuan Li

Department of Chemistry

V

Valerie Bowering

P

Pam Ohashi

B

Ben Wang

State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, China

A

Amit M. Oza